Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention

Background: Although statins decrease mortality in coronary artery disease, the effect of high-dose statins and duration of therapy post-percutaneous coronary intervention (PCI) is not well addressed. Aim: To determine the effective dose of statin to prevent major adverse cardiovascular events (MACE...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehrevar, Morteza, Vafa, Reza Golchin, Rahmani, Mohammadhossein, Parizi, Mohammadjavad Mehdizadeh, Ahmadi, Amin, Zamiri, Bardia, Heydarzadeh, Reza, Montaseri, Mohammad, Hosseini, Seyed Ali, Kojuri, Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2022
Materias:
Coronary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987507/
https://www.ncbi.nlm.nih.gov/pubmed/36890806
http://dx.doi.org/10.15420/icr.2022.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987507/
https://www.ncbi.nlm.nih.gov/pubmed/36890806
http://dx.doi.org/10.15420/icr.2022.13

Ejemplares similares